학술논문
PARP1 inhibition by Olaparib reduces the lethality of pancreatic cancer cells and increases their sensitivity to Gemcitabine
Document Type
Article
Author
Source
In: Biomedicine and Pharmacotherapy . (Biomedicine and Pharmacotherapy, November 2022, 155)
Subject
Language
English
ISSN
19506007
07533322
07533322